This company has been acquired
The company may no longer be operating, as it has been acquired. Find out why through their latest events.
このページの翻訳は実験的なもので、現在開発中です。お待ちしております
AGTC 株式概要
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases.
Applied Genetic Technologies Corporation 競合他社
価格と性能
| 過去の株価 | |
|---|---|
| 現在の株価 | US$0.39 |
| 52週高値 | US$2.83 |
| 52週安値 | US$0.23 |
| ベータ | 1.58 |
| 11ヶ月の変化 | -4.23% |
| 3ヶ月変化 | -1.85% |
| 1年変化 | -80.89% |
| 33年間の変化 | -86.79% |
| 5年間の変化 | -89.78% |
| IPOからの変化 | -97.33% |
最新ニュース
Recent updates
AGTC receives positive feedback from FDA for manufacturing facility
Jul 26Applied Genetic Technologies proposes stock offering to fund clinical trials
Jul 12Applied Genetic Tech: A Speculative Biotech With Potential To Turn Corner In 2022
Jan 12An Assessment Of Applied Genetic Technologies Corporation
Dec 14Applied Genetic Technologies: Weak Early Clinical Ocular Results Highlight Increased Risk
Jul 15Is Applied Genetic Technologies (NASDAQ:AGTC) A Risky Investment?
May 21
Applied Genetic trades lower after announcing the departure of chief scientific officer
Apr 26What Is The Ownership Structure Like For Applied Genetic Technologies Corporation (NASDAQ:AGTC)?
Feb 05
Is Applied Genetic Technologies (NASDAQ:AGTC) Using Debt In A Risky Way?
Jan 06What Type Of Returns Would Applied Genetic Technologies'(NASDAQ:AGTC) Shareholders Have Earned If They Purchased Their SharesFive Years Ago?
Dec 11Interim data on gene therapy for vision loss disorder fails to lift Applied Genetic
Nov 11株主還元
| AGTC | US Biotechs | US 市場 | |
|---|---|---|---|
| 7D | 4.8% | 0.6% | 0.8% |
| 1Y | -80.9% | 27.4% | 38.3% |
業界別リターン: AGTC underperformed the US Biotechs industry which returned -10.2% over the past year.
リターン対市場: AGTC underperformed the US Market which returned -14.8% over the past year.
価格変動
| AGTC volatility | |
|---|---|
| AGTC Average Weekly Movement | 19.5% |
| Biotechs Industry Average Movement | 9.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 14.8% |
| 10% least volatile stocks in US Market | 3.0% |
安定した株価: AGTC's share price has been volatile over the past 3 months.
時間の経過による変動: AGTC's weekly volatility (20%) has been stable over the past year, but is still higher than 75% of US stocks.
会社概要
| 設立 | 従業員 | CEO（最高経営責任者 | ウェブサイト |
|---|---|---|---|
| 1999 | 102 | Sue Washer | agtc.com |
Applied Genetic Technologies Corporation 基礎のまとめ
| AGTC 基礎統計学 | |
|---|---|
| 時価総額 | US$12.62m |
| 収益（TTM） | -US$70.23m |
| 売上高(TTM) | US$325.00k |
38.9x
P/Sレシオ-0.2x
PER（株価収益率AGTC は割高か？
公正価値と評価分析を参照収益と収入
| AGTC 損益計算書（TTM） | |
|---|---|
| 収益 | US$325.00k |
| 売上原価 | US$21.76m |
| 売上総利益 | -US$21.44m |
| その他の費用 | US$48.80m |
| 収益 | -US$70.23m |
直近の収益報告
Sep 30, 2022
次回決算日
該当なし
| 一株当たり利益（EPS） | -2.19 |
| グロス・マージン | -6,596.62% |
| 純利益率 | -21,610.46% |
| 有利子負債／自己資本比率 | 92.6% |
AGTC の長期的なパフォーマンスは？
過去の実績と比較を見る